Helping to Prevent Pressure Ulcers
Around 412,000 people are likely to develop a pressure ulcer annually1, including 4-10% of patients admitted to hospital2. An estimated 31% are category III or IV (EPUAP)3, causing severe pain and discomfort to the patient.

ADERMA is designed to help prevent pressure ulcers. It is a range of dermal gel pads that redistribute pressure to protect critical areas. It is typically used on bony areas to help prevent skin damage from pressure, most notably the heel and sacrum.

ADERMA dermal pads are an excellent addition to any care plan for at-risk patients and they can be washed and re-used by the same patient. More and more hospitals and primary care trusts are using the ADERMA products to reach their targets of reducing the number of pressure ulcers in their area.

One study showed that ADERMA contributed to a 75% drop in the number of pressure ulcers when added to a care plan in an acute trust across 4 wards4. A study across 3 nursing homes showed a visual and below-the-skin improvement when used on category I pressure ulcers which all returned to a pre-injured state within weeks of commencing treatment5.
4-10% of patients admitted
to hospital develop a pressure ulcer2
The average cost to treat
one category IV pressure ulcer is £14,1086
ADERMA contributed to a 75% reduction in the number of pressure ulcers4
References >